Rabies Vaccine

Rabies Vaccines & Immunoglobulin

Clinical-Grade Solutions for Human Use

Rabies remains one of the deadliest zoonotic diseases, yet fully preventable with timely access to the right biologics. Pharmint provides a curated portfolio of GMP-certified rabies vaccines and anti-rabies immunoglobulin solutions designed for hospitals, health ministries, NGOs, and clinical buyers worldwide.

Our lineup includes human-use rabies vaccines like Vaxirab-Z, Abhayrab, and Zoonovac-V, along with passive immunization agents such as Anti-Rabies Immunoglobulin and Berab.

All products are backed by regulatory-grade documentation (COA, MSDS) and suitable for post-exposure prophylaxis (PEP) and pre-exposure protocols.

Whether you’re sourcing for public health campaigns or cold-chain export, Pharmint ensures end-use-ready compliance and global delivery.

What Are Rabies Vaccines and Immunoglobulin?

Rabies prevention relies on a dual approach: active immunization via vaccines and passive protection via immunoglobulin. Each plays a distinct role in managing exposure risks—especially in emergency and high-incidence settings.

Rabies Vaccines – Active Immunization

Rabies vaccines are inactivated biological agents that train the immune system to recognize and defend against the rabies virus. They’re used both for pre-exposure (high-risk professionals, travelers) and post-exposure prophylaxis (PEP) following animal bites.

Trusted formulations available on Pharmint include:

• Abhayrab 2.5 IU – ideal for routine PEP
• Zoonovac-V Injection – widely adopted in institutional supply
• Rabies Vaccine IP 0.5 mL – ready-to-use dosage
• Rabio Vaccine – suitable for hospital restocking

Anti-Rabies Immunoglobulin – Passive Immunization

Immunoglobulin products deliver instant antibodies that neutralize the rabies virus at the site of exposure. They’re crucial for PEP when there’s a delay in vaccination or for immunocompromised patients.

On Pharmint, Anti-Rabies Immunoglobulin and Berab are available for clinical-grade passive therapy.

Together, vaccines and immunoglobulin form a WHO-endorsed treatment protocol—administered concurrently but at different anatomical sites.

Featured Rabies Vaccines & Immunoglobulin on Pharmint

Pharmint simplifies institutional sourcing by offering pre-qualified, human-use rabies biologics across various dosage formats and clinical needs. Below are key products available for bulk purchase, each with supporting documentation and compliant labeling.

Top-Selling Rabies Vaccines (Active Immunization)

• Vaxirab-Z (Zydus) – prescription-grade vaccine used in public sector immunization drives
• Zoonovac-V Injection – high-uptake option among global buyers
• SII Rabiyax (1 mL) – from Serum Institute, ideal for rapid supply
• Abhayrab 2.5 IU – reliable formulation for urgent PEP cases
• Rabies Vaccine IP 0.5 mL – compact packaging, ready-to-use
• Rabio Vaccine – sterile vial format for institutional stock

Rabies Immunoglobulin (Passive Immunization)

• Anti-Rabies Immunoglobulin – immediate virus-neutralizing antibody for post-bite cases
• Berab – used alongside vaccines for enhanced PEP protection

Veterinary or Clinical Supply Only

• Nobivac Rabies 10 mL – not intended for human use; suited for veterinary or controlled lab environments

Where These Products Fit: Real-World Use Scenarios

• Hospital Emergency Kits: Rabio and Zoonovac-V are used in bite-response protocols across Asia and Africa.
• NGO Procurement: Berab and Anti-Rabies Immunoglobulin are stocked for rural deployment.
• Public Health Programs: Governments contract Vaxirab-Z and SII Rabiyax for national immunization schedules.
• Cold Chain Export: Pharmint exports Abhayrab and Zoonovac-V globally with full compliance and COA.

What Should Buyers Consider When Procuring Rabies Vaccines and Immunoglobulin?

Sourcing rabies biologics requires more than just selecting a product—it involves evaluating regulatory compliance, dosage formats, cold chain logistics, and documentation support. Pharmint ensures every stage aligns with institutional procurement needs and international shipment protocols.

• Dosage Formats & Clinical Use: Our rabies vaccines are available in single-dose ampoules, multi-dose vials, and 1 mL or 0.5 mL injections. For instance, Rabies Vaccine IP 0.5 mL is ideal for direct clinical use, while SII Rabiyax and Abhayrab provide flexibility for emergency dosing schedules. Immunoglobulins such as Berab are optimized for co-administration during post-exposure treatment.
• Regulatory Documents & Certifications: Each product is supported by batch-specific COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and import/export clearance files. Products like Zoonovac-V and Rabio meet stringent GMP norms and are suitable for public health tenders or institutional purchases.
• Cold Chain Storage & Logistics: Rabies vaccines and immunoglobulin require 2–8°C refrigerated storage throughout their lifecycle. Pharmint provides validated cold-box transit solutions, ideal for buyers in temperature-sensitive regions across Africa, LATAM, Central Asia, and Southeast Asia.
• Prescription-Only Access: All listed human-use rabies biologics are Rx-grade—not for over-the-counter sale. Buyers must provide appropriate documentation, including an End-Use Declaration (EUD) for exports.

What Compliance and Export Requirements Apply to Rabies Biologics?

When sourcing rabies vaccines or immunoglobulin for institutional or global distribution, regulatory alignment is crucial. Pharmint ensures that all biologics are document-ready, export-compliant, and eligible for global deployment—from government tenders to humanitarian use.

• End-Use Declaration (EUD): For international orders, especially involving controlled biologics like Anti-Rabies Immunoglobulin or Berab, Pharmint requires a valid End-Use Declaration (EUD). This ensures lawful application in human health programs and aligns with national regulatory frameworks.
• GMP Certification & WHO Compatibility: Many of our rabies vaccines, such as Zoonovac-V and SII Rabiyax, are manufactured in WHO-aligned GMP facilities. While not all are WHO-prequalified, they meet public sector procurement specs in Africa, Asia, and LATAM.
• Cold Chain Documentation & Validation: Pharmint provides full cold chain assurance, including temperature loggers, validation certificates, and insulated packaging for international delivery. This is essential for maintaining potency and regulatory acceptance on arrival.
• Not for Human/Veterinary OTC Use: All human-use rabies products are prescription-grade. For example, Nobivac Rabies 10 mL is restricted to clinical or veterinary use only, and is clearly labeled as such. No product listed is permitted for general over-the-counter sale.

Rabies Vaccines & Immunoglobulin FAQs

What is the difference between rabies vaccine and immunoglobulin?

Rabies vaccine induces long-term immunity, while immunoglobulin offers immediate passive protection. Both are used together in post-exposure protocols.

Can rabies immunoglobulin and vaccine be co-administered?

Yes, immunoglobulin like Berab is given with vaccines like Zoonovac-V, but at separate injection sites.

Are these rabies biologics WHO prequalified?

While not all are WHO-prequalified, products like SII Rabiyax are GMP-certified and meet public health procurement specs.

Can I buy rabies immunoglobulin in bulk for hospital use?

Yes, Pharmint supplies bulk-packed Anti-Rabies Immunoglobulin with COA, MSDS, and end-use compliance support.

What’s the storage requirement for rabies vaccines?

All vaccines must be stored between 2–8°C. Pharmint ensures validated cold-chain packaging for global deliveries.